News
ReShape Lifesciences will distribute Motion Informatics' FDA-cleared Stimel-03 rehab device in the U.S., targeting stroke and ...
ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that it has signed ...
ReShape Enters Exclusive U.S. Distribution Agreement in the Neuromuscular Rehabilitation MarketIRVINE, Calif., April 09, 2025 ...
CBLL's lockup expiration on April 9th could impact share prices. Click here to find out why CBLL stock is a Sell.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results